Teriparatide for tibia stress fracture recovery for duty
Treatments studied
Part of Bones, joints & muscles, Injuries & trauma clinical trials.
This trial tests teriparatide, a medication that helps build bone, to see if it can speed recovery and help certain enlisted Army members return to training duty after a tibia bone injury. You may be asked to self-administer the medication while you recover and take part in study follow-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an actively enlisted U.S. Army soldier assigned to basic training at Fort Jackson.
- You need a confirmed tibia (shinbone) stress injury that requires time off for recovery (“convalescent leave”).
- You must be skeletally mature (your growth plates are closed).
- You must be willing and able to give yourself the study medicine as instructed.
- You must want to continue your military commitment and be able to follow study plans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This study tests a daily injection that may help heal broken pelvic or leg bones faster in people with certain health conditions like diabetes or smoking. It is for adults 50 and older who have had a low-energy fracture.
This trial studies rehabilitation after a tibia (shinbone) shaft fracture that is fixed with a metal nail. You may be asked to complete questionnaires and to take part in a rehab plan that aims to improve recovery after injury.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
This trial tests a daily injection called abaloparatide, which helps strengthen bones and reduce the chance of breaking a bone. It is for postmenopausal women with osteoporosis who are at higher risk of fractures.
This trial tests whether a bone stimulator device can help heal a specific type of spinal stress fracture (spondylolysis) in people aged 16 to 40 who are active in sports and plan to do physical therapy.
Hear when a new Stress Fracture of Tibia or Fibula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.